NEW CYCLOHEXYLAMINE DERIVATIVES HAVING .BETA.2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES

The present invention relates to novel compounds of Formula IC having .beta.2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies. La présente invention concerne...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PRAT QUINONES, MARIA, GUAL ROIG, SILVIA, AIGUADE BOSCH, JOSE, PUIG DURAN, CARLOS
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to novel compounds of Formula IC having .beta.2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies. La présente invention concerne de nouveaux composés ayant une double activité d'agoniste des récepteurs ß2-adrénergiques et d'antagoniste des récepteurs muscariniques M3, des compositions pharmaceutiques les contenant, leur procédé de préparation et leur application dans les traitements respiratoires.